Jennifer Maria Johnson

7PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 16, 2026
Molecular Profiling and Real-world Outcomes of BRAF V600E-Mutated Papillary Thyroid Cancer.

Martina Chirra, Andrew Elliott, Hira Shaikh

|Dec 12, 2025
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.

Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson

|Sep 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena, Hani Samarah, Kathryn Nunes

|Nov 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.

Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena

|Oct 10, 2024
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.

Priyan Bhattacharya, Alban Linnenbach, Andrew P South

|Apr 04, 2024
From Base Pairs to City Squares: Comprehensive Precision Oncology for the Future.

Amy E Leader, Christopher M McNair, Jennifer M Johnson

Pageof 2

Frequent Collaborators

4 joint publications

Athanassios Argiris

4 joint publications

Larry Harshyne

4 joint publications

Joseph M Curry

3 joint publications

Madalina Tuluc